310 related articles for article (PubMed ID: 12602501)
1. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission.
Monfort P; Muñoz MD; ElAyadi A; Kosenko E; Felipo V
Metab Brain Dis; 2002 Dec; 17(4):237-50. PubMed ID: 12602501
[TBL] [Abstract][Full Text] [Related]
2. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.
Cauli O; Rodrigo R; Llansola M; Montoliu C; Monfort P; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Metab Brain Dis; 2009 Mar; 24(1):69-80. PubMed ID: 19085094
[TBL] [Abstract][Full Text] [Related]
3. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
Rodrigo R; Felipo V
Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
[TBL] [Abstract][Full Text] [Related]
4. Clinical aspects of urea cycle dysfunction and altered brain energy metabolism on modulation of glutamate receptors and transporters in acute and chronic hyperammonemia.
Natesan V; Mani R; Arumugam R
Biomed Pharmacother; 2016 Jul; 81():192-202. PubMed ID: 27261594
[TBL] [Abstract][Full Text] [Related]
5. Glutamine synthetase in brain: effect of ammonia.
Suárez I; Bodega G; Fernández B
Neurochem Int; 2002; 41(2-3):123-42. PubMed ID: 12020613
[TBL] [Abstract][Full Text] [Related]
6. Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations.
Llansola M; Montoliu C; Cauli O; Hernández-Rabaza V; Agustí A; Cabrera-Pastor A; Giménez-Garzó C; González-Usano A; Felipo V
Metab Brain Dis; 2013 Jun; 28(2):151-4. PubMed ID: 23010935
[TBL] [Abstract][Full Text] [Related]
7. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo.
Cabrera-Pastor A; Taoro-Gonzalez L; Felipo V
J Neurochem; 2016 May; 137(4):539-48. PubMed ID: 26875688
[TBL] [Abstract][Full Text] [Related]
8. Chronic hyperammonemia alters protein phosphorylation and glutamate receptor-associated signal transduction in brain.
Corbalán R; Hernández-Viadel M; Llansola M; Montoliu C; Felipo V
Neurochem Int; 2002; 41(2-3):103-8. PubMed ID: 12020610
[TBL] [Abstract][Full Text] [Related]
9. Interplay between glutamatergic and GABAergic neurotransmission alterations in cognitive and motor impairment in minimal hepatic encephalopathy.
Llansola M; Montoliu C; Agusti A; Hernandez-Rabaza V; Cabrera-Pastor A; Gomez-Gimenez B; Malaguarnera M; Dadsetan S; Belghiti M; Garcia-Garcia R; Balzano T; Taoro L; Felipo V
Neurochem Int; 2015 Sep; 88():15-9. PubMed ID: 25447766
[TBL] [Abstract][Full Text] [Related]
10. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
11. Glutamate transporter and receptor function in disorders of ammonia metabolism.
Butterworth RF
Ment Retard Dev Disabil Res Rev; 2001; 7(4):276-9. PubMed ID: 11754522
[TBL] [Abstract][Full Text] [Related]
12. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission.
Norenberg MD; Huo Z; Neary JT; Roig-Cantesano A
Glia; 1997 Sep; 21(1):124-33. PubMed ID: 9298855
[TBL] [Abstract][Full Text] [Related]
13. Chronic hyperammonemia alters extracellular glutamate, glutamine and GABA and membrane expression of their transporters in rat cerebellum. Modulation by extracellular cGMP.
Cabrera-Pastor A; Arenas YM; Taoro-Gonzalez L; Montoliu C; Felipo V
Neuropharmacology; 2019 Dec; 161():107496. PubMed ID: 30641078
[TBL] [Abstract][Full Text] [Related]
14. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
Rodrigo R; Montoliu C; Chatauret N; Butterworth R; Behrends S; Del Olmo JA; Serra MA; Rodrigo JM; Erceg S; Felipo V
Neurochem Int; 2004 Nov; 45(6):947-53. PubMed ID: 15312989
[TBL] [Abstract][Full Text] [Related]
15. Glutamate transporters in hyperammonemia.
Butterworth RF
Neurochem Int; 2002; 41(2-3):81-5. PubMed ID: 12020607
[TBL] [Abstract][Full Text] [Related]
16. Glutamate uptake.
Danbolt NC
Prog Neurobiol; 2001 Sep; 65(1):1-105. PubMed ID: 11369436
[TBL] [Abstract][Full Text] [Related]
17. Blocking glycine receptors reduces neuroinflammation and restores neurotransmission in cerebellum through ADAM17-TNFR1-NF-κβ pathway.
Arenas YM; Cabrera-Pastor A; Juciute N; Mora-Navarro E; Felipo V
J Neuroinflammation; 2020 Sep; 17(1):269. PubMed ID: 32917219
[TBL] [Abstract][Full Text] [Related]
18. Roles of Glutamate and Glutamine Transport in Ammonia Neurotoxicity: State of the Art and Question Marks.
Dabrowska K; Skowronska K; Popek M; Obara-Michlewska M; Albrecht J; Zielinska M
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):306-315. PubMed ID: 29256360
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptors in hyperammonemia and hepatic encephalopathy.
Llansola M; Rodrigo R; Monfort P; Montoliu C; Kosenko E; Cauli O; Piedrafita B; El Mlili N; Felipo V
Metab Brain Dis; 2007 Dec; 22(3-4):321-35. PubMed ID: 17701332
[TBL] [Abstract][Full Text] [Related]
20. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.
Felipo V
World J Gastroenterol; 2006 Dec; 12(48):7737-43. PubMed ID: 17203513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
